Literature DB >> 20887338

Hepatitis B virus/hepatitis C virus upregulate angiopoietin-2 expression through mitogen-activated protein kinase pathway.

Yanmei Li1, Jizheng Chen, Chunchen Wu, Linding Wang, Mengji Lu, Xinwen Chen.   

Abstract

AIM: To explore the molecular mechanism of hepatitis B virus (HBV)/hepatitis C virus (HCV) upregulate angiopoietin-2 (Ang-2) expression.
METHODS: Reverse transcription polymerase chain reaction (RT-PCR), quantitative real-time (qRT)-PCR and enzyme-linked immunosorbent assay (ELISA) analysis were used to measure the Ang-2 transcription and expression level. Reporter gene assays were used to determine the cis-element of the Ang-2 promoter. The specific inhibitors assay, immunofluorescence and western blot analysis were conducted to verify the signal pathway involved in the upregulation of Ang-2 expression.
RESULTS: The level of transcription and expression of Ang-2 increased in the HepG2.2.15 and Con-1 cells. Reporter gene assays in HepG2.2.15 and Con-1 cells revealed that HBV/HCV could enhance Ang-2 promoter expression by activating AP-1 and Ets1. Analysis with specific inhibitors indicated that HBV/HCV upregulated the expression of Ang-2 through mitogen-activated protein kinase (MAPK) pathways.
CONCLUSION: This study illustrates a distinct mechanism by which a tumor virus modulates vasculature to promote tumorigenesis.
© 2010 The Japan Society of Hepatology.

Entities:  

Year:  2010        PMID: 20887338     DOI: 10.1111/j.1872-034X.2010.00712.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  9 in total

Review 1.  Hepatitis C virus-mediated angiogenesis: molecular mechanisms and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Martine Soell; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mosaad Megahed
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

2.  Novel evidence suggests Hepatitis B virus surface proteins participate in regulation of HBV genome replication.

Authors:  Jian Qiu; Bo Qin; Simon Rayner; Chun-chen Wu; Rong-juan Pei; Song Xu; Yun Wang; Xin-wen Chen
Journal:  Virol Sin       Date:  2011-04-07       Impact factor: 4.327

Review 3.  Morphogens and blood-brain barrier function in health and disease.

Authors:  Nienke R Wevers; Helga E de Vries
Journal:  Tissue Barriers       Date:  2015-09-11

Review 4.  Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update.

Authors:  Gulsum Ozlem Elpek
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

Review 5.  Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection.

Authors:  Mohammad Irshad; Priyanka Gupta; Khushboo Irshad
Journal:  World J Hepatol       Date:  2017-12-28

6.  HBV Upregulates CtBP2 Expression via the X Gene.

Authors:  Xinghui Liu; Chengliang Zhu; Jie Li; Fengxia Xu; Gang Huang; Limin Xu; Binghong Zhang
Journal:  Biomed Res Int       Date:  2018-07-31       Impact factor: 3.411

7.  Inhibition of tyrosine kinase receptor Tie2 reverts HCV-induced hepatic stellate cell activation.

Authors:  Samuel Martín-Vílchez; Yolanda Rodríguez-Muñoz; Rosario López-Rodríguez; María Jesús Borque-Iñurrita; Francisca Molina-Jiménez; Luisa García-Buey; Ricardo Moreno-Otero; Paloma Sanz-Cameno
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

8.  Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells.

Authors:  Yu-Yun Shao; Min-Shu Hsieh; Han-Yu Wang; Yong-Shi Li; Hang Lin; Hung-Wei Hsu; Chung-Yi Huang; Chih-Hung Hsu; Ann-Lii Cheng
Journal:  Oncotarget       Date:  2017-09-30

Review 9.  Role of Angiopoietins in Development of Cancer and Neoplasia Associated with Viral Infection.

Authors:  Xiaolan Yu; Fengchun Ye
Journal:  Cells       Date:  2020-02-18       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.